 Colchicine antineoplastic therapy prevention restenosis percutaneous coronary interventions complexity events intimal proliferation arterial injury similarities response benign neoplasia conventional medical therapies unsuccessful recurrent stenosis percutaneous coronary revascularization cell division smooth muscle cell activation antimitogenic therapy final common pathway complex chain events apparent loss local growth control Colchicine metaphase arrest cell division experimental studies extent atheromatous plaque formation severity arterial restenosis balloon angioplasty preliminary results placebo-controlled clinical trial low dose colchicine mg day restenosis use potent antineoplastic agents potential life-threatening side effects possible adverse effects novel drug delivery systems antimitogenic therapy site arterial injury low dose synergistic combinations antiproliferative agents review potential role antimitogenic therapy prevention restenosis coronary interventions possibility overlap therapeutic realms interventional cardiology medical oncology